Document Detail


Educating for personalized medicine: a perspective from oncology.
MedLine Citation:
PMID:  19536120     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The personalized-medicine concept represents the future of oncology medicine. New genomics technologies will characterize patients biologically in ways that will drive more efficient and effective cancer treatment. Yet the introduction of these technologies is disruptive to current practices in clinical oncology, as well as to current regulatory and reimbursement strategies. The efficient introduction of personalized medicine will require education in addition to behavioral and policy changes by the various involved stakeholders.
Authors:
D R Parkinson; J Ziegler
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  86     ISSN:  1532-6535     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-18     Completed Date:  2009-07-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  23-5     Citation Subset:  AIM; IM    
Affiliation:
Nodality, South San Francisco, California, USA. david.parkinson@nodality.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Medical Oncology / education*,  trends*
Patient Education as Topic / trends*
Personal Health Services / trends*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Personalized medicine: a perk of privilege?
Next Document:  Biomarkers in clinical drug development.